Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    e2810
Show Display Options
Rank Status Study
1 Recruiting Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Conditions: Clear Cell Renal Cell Carcinoma;   Recurrent Renal Cell Carcinoma;   Stage IV Renal Cell Cancer
Interventions: Drug: Pazopanib Hydrochloride;   Other: Placebo;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Other: Pharmacological Study
2 Recruiting CYP19A1 Gene and Pharmacogenetics of Response to Testosterone Therapy
Condition: Hypogonadism
Intervention: Drug: Testosterone Cypionate
3 Unknown  Integrating Well-Woman and Well-Baby Care to Improve Parenting and Family Wellness
Condition: Primary Care
Interventions: Other: Centering parenting/Group well child care;   Other: Standard Care
4 Recruiting Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Exenatide Once Weekly;   Drug: Placebo
5 Completed
Has Results
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium bromide;   Drug: Salmeterol;   Drug: Placebo Salmeterol;   Drug: Placebo Tiotropium
6 Recruiting A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
Condition: Cutaneous Melanoma
Intervention:

Indicates status has not been verified in more than two years